from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1718/-

LFCtreatmentdescriptionclass of inhibitor

-0.664

Amikacinug/mL Amikacintranslation

-0.246

Cap5-10ug/mL Capreomycintranslation

-0.316

Rox10-50 ug/mL Roxithromycintranslation

-1.118

SM2-5 ug/mL Streptomycintranslation

-1.609

Tet5-10 ug/mL Tetracyclinetranslation

-0.178

Rif0.2-5ug/mL Rifampicintranscription

0.272

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.820

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.486

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.174

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.178

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.334

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.646

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.121

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.204

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.039

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.440

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.401

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.762

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.111

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.845

KCN5-20 ug/mL Potassium cyaniderespiration

-0.190

NaN30.2-2 mM Sodium aziderespiration

-0.832

Nigericin50 uM Nigericinrespiration

0.682

TRC10-150 ug/mL Triclosanrespiration

1.238

TRZ10-25 ug/mL Thioridazinerespiration

0.022

Valinomycin0.5-10 uM Valinomycinrespiration

-0.642

ZnSO42 mM ZnSO4respiration

0.387

menadione6-10 ug/mL Menadionerespiration

0.415

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.617

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.143

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.026

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.206

NRP_1Non-replicating persistence stage 1dosRassociated

-0.550

Amp0.2mg/mL AmpicillincellWall

0.382

Cephalexin20-100 ug/mL CephalexincellWall

-0.083

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.437

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.524

EMB10-20 ug/mL EthambutolcellWall

-1.334

Eta12-40 ug/mL EthionamidecellWall

-1.332

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.478

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.260

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.580

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.047

BZA0.12 mg/mL BenzamidearomaticAmides

0.200

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.129

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.731

H2O24 mM hydrogen peroxideDNAdamaging

0.771

Levo10 ug/mL LevofloxacinDNAdamaging

0.382

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.300

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.056

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.307

UVUV-irradiationDNAdamaging

0.660

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.010

Antimycin12.5-50 ug/mL Antimycin A?

-0.107

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.861

PA_110-50 ug/mL Antitubercular compound PA-1?

0.524

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.807

PA8240.2-2 ug/mL PA-824?

0.175

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.491

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.118

Verapamil50 uM Verapamil?

-0.120

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.836

methoxatin10-20 ug/mL Methoxatin?